First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
48.94
+2.60 (5.61%)
Nov 4, 2026, 4:00 PM EST - Market closed

TRAX Statistics

Total Valuation

TRAX has a market cap or net worth of $2.06 billion. The enterprise value is $1.90 billion.

Market Cap2.06B
Enterprise Value 1.90B

Important Dates

The last earnings date was Tuesday, November 3, 2026, after market close.

Earnings Date Nov 3, 2026
Ex-Dividend Date n/a

Share Statistics

TRAX has 42.02 million shares outstanding.

Current Share Class 42.02M
Shares Outstanding 42.02M
Shares Change (YoY) n/a
Shares Change (QoQ) +2.13%
Owned by Insiders (%) 1.56%
Owned by Institutions (%) 72.75%
Float 34.47M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 11.02
P/TBV Ratio 13.57
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.16, with a Debt / Equity ratio of 0.02.

Current Ratio 9.16
Quick Ratio 8.60
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -103.28%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 39.10
200-Day Moving Average n/a
Relative Strength Index (RSI) 72.94
Average Volume (20 Days) 1,184,779

Short Selling Information

The latest short interest is 6.96 million, so 16.56% of the outstanding shares have been sold short.

Short Interest 6.96M
Short Previous Month 5.19M
Short % of Shares Out 16.56%
Short % of Float 20.19%
Short Ratio (days to cover) 6.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -157.36M
Pretax Income -149.80M
Net Income -149.80M
EBITDA -156.91M
EBIT -157.36M
Earnings Per Share (EPS) -$4.17
Full Income Statement

Balance Sheet

The company has $155.63 million in cash and $3.77 million in debt, with a net cash position of $151.85 million or $3.61 per share.

Cash & Cash Equivalents 155.63M
Total Debt 3.77M
Net Cash 151.85M
Net Cash Per Share $3.61
Equity (Book Value) 151.01M
Book Value Per Share 4.21
Working Capital 147.63M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$110.12 million and capital expenditures -$43,000, giving a free cash flow of -$110.17 million.

Operating Cash Flow -110.12M
Capital Expenditures -43,000
Depreciation & Amortization 453,000
Net Borrowing n/a
Free Cash Flow -110.17M
FCF Per Share -$2.62
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TRAX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -8.53%
FCF Yield -5.38%

Analyst Forecast

The average price target for TRAX is $74.17, which is 51.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target $74.17
Price Target Difference 51.55%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1